Lilly to Invest $1.6 Billion in Indiana Manufacturing Facilities

Eli Lilly is investing an additional $1.6 billion and adding another 200 new jobs at its two new manufacturing sites within LEAP Innovation Park in Boone County, Ind. Lilly’s commitments within LEAP Innovation Park represent the largest manufacturing investment at a single location in the company’s history.

Lilly’s investments in its facilities, such as those at LEAP Innovation Park, will expand the company’s manufacturing network for active pharmaceutical ingredients, support increased demand for existing Lilly products, and play a key role in bringing the next generation of therapeutic modalities, including genetic medicines, to patients globally.

The company also has committed $15 million over five years to the Ivy Tech Foundation to fund up to 1,000 scholarships for individuals interested in pursuing careers in pharmaceutical manufacturing. Through the Lilly Scholars @ Ivy Tech program, students will be able to access a smart manufacturing lab to support their education. Preference will be given to those who are among the first generation in their family to attend college—which constitutes 40% of Ivy Tech's student population—and those who have overcome socioeconomic disadvantages.

Additionally, the program supports a new pathway for high school students, which allows them to receive a college certificate in pharmaceutical manufacturing or medical device quality upon graduation.

“Through these new facilities, Hoosiers will make life-changing medicines that patients around the world need to address serious health challenges, including diabetes and cancer,” says Lilly’s chair and CEO Dave Ricks. “We’re investing at record levels in our home state to help our communities and economy thrive and enhance educational opportunities for more students. We look forward to doing our part to make Indiana an even better place to work and live, while fostering cutting-edge innovation in our state.”